(Q77937414)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9928921%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

The speech analysis approach to determining onset of improvement under antidepressants (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9928921%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

H H Stassen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9928921%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

S Kuny

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9928921%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

D Hell

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9928921%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 December 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9928921%20AND%20SRC:MED&resulttype=core&format=json

European Neuropsychopharmacology

9 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9928921%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9928921%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9928921%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

303-310

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9928921%20AND%20SRC:MED&resulttype=core&format=json

Mapping schizophrenic negative symptoms onto measures of the patient's speech: set correlational analysis

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900090-4

7 January 2021

Cumulative mean change procedure: application to a comparative trial of venlafaxine, imipramine, and placebo in the treatment of major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900090-4

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900090-4

7 January 2021

The timing, specificity and clinical prediction of tricyclic drug effects in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900090-4

7 January 2021

Onset of response in relation to outcome in depressed outpatients with placebo and imipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900090-4

7 January 2021

Speaking behavior and voice sound characteristics in depressive patients during recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900090-4

7 January 2021

Onset and duration: measurement and analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900090-4

7 January 2021

How to assess the onset of antidepressant effect: comparison of global ratings and findings based on depression scales

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900090-4

7 January 2021

Rapid onset of action of venlafaxine.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900090-4

7 January 2021

Measuring the rate of change of voice fundamental frequency in fluent speech during mental depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900090-4

7 January 2021

On brightening up: triggers and trajectories to recovery from depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900090-4

7 January 2021

Use of pattern analysis to identify true drug response. A replication

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900090-4

7 January 2021

Further evidence that a placebo response to antidepressants can be identified

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900090-4

7 January 2021

Psychomotor symptoms of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900090-4

7 January 2021

Time course of improvement under antidepressant treatment: a survival-analytical approach

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900090-4

7 January 2021

Speaking behavior and voice sound characteristics associated with negative schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900090-4

7 January 2021

Delayed onset of action of antidepressant drugs? Survey of results of Zurich meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900090-4

7 January 2021

Onset of improvement under fluoxetine and moclobemide

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900090-4

7 January 2021

How long to onset of antidepressant action: a meta-analysis of patients treated with fluoxetine or placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900090-4

7 January 2021

10.1016/S0924-977X(97)00090-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9928921%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference